Monthly Communication Report

Corporation:	The Canada Life Assurance Company/de la Compagnie d'Assurance du Canada sur la Vie
Associated registration:	871793-224181-53
Communication date:	2025-03-21
Posted date:	2025-04-15

Designated Public Office Holders who participated in the communication:	Daniel MacDonald, Director General Health Canada (HC) Margaret Sharp, Director Office of Pharmaceutical Management Strategies, Health Canada (HC)
List of Details Subject matter Detail Health Healthcare policy and potential legislation relating to employee benefit programs and the cost of pharmaceuticals, and healthcare policy related to virtual care services Health Seeking to raise awareness about prescription drug coverage policy considerations and concerns in context of national universal pharmacare proposals directly and as a participant in the Together for Better Health Coalition. Other related initiatives include high cost drugs for rare disease and PMPRB regulations
Responsible Officer who filed this communication report:	Paul Mahon
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.